Ann: Phosphagenics Pain Program Update , page-53

This is all well and good but it disappoints me if this means parking oxy and waiting for every pain related patch to spend the next however many months or years going through the same hoops.

IF your surmise were true, I think everyone would not only be disappointed but we'd be taking up pitchforks, plucking chickens and heating up the tar.

But, fortunately there is no reason to leap to that conclusion. The only place oxy is "parked" is in your imagination.

I would've thought if you had a product that you were confident could go all the way, you'd go hell for leather. Until today, I and some others here thought that was still the strategy.

But now, you have concluded that instead, the company has adopted a "foot on the brake" strategy for optimizing shareholder value! LOL! I really think you ought to put in a call to Harry Rosen and get yourself personally straightened out on this point.